Parametrica Management’s Cantel Medical Corporation CMD Stock Holding History

Parametrica Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-17,798	Closed	-$787K	–	172
2020 Q2	$787K	Buy	+17,798	New	+$664K	0.86%	29
2019 Q1	–	Sell	-3,029	Closed	-$226K	–	342
2018 Q4	$226K	Buy	+3,029	New	+$250K	0.28%	197
2018 Q2	–	Sell	-3,778	Closed	-$421K	–	211
2018 Q1	$421K	Buy	+3,778	New	+$423K	0.52%	47
2017 Q1	–	Sell	-8,209	Closed	-$646K	–	390
2016 Q4	$646K	Buy	+8,209	New	+$638K	0.64%	53

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Parametrica Management's CMD Position: Q3 2020 in Review

Parametrica Management sold out of Cantel Medical Corporation (CMD) in Q3 2020, closing a stake of 17,798 shares — an estimated $787K sold.

Parametrica Management first reported a position in CMD in Q4 2016 and held it in 4 quarters. The position peaked at $787K in Q2 2020. 196 funds tracked by Wall St. Rank hold CMD as of Q3 2020.

Parametrica Management reported no remaining Cantel Medical Corporation position as of Q3 2020 after selling out during the quarter.
Parametrica Management sold 17,798 Cantel Medical Corporation shares in Q3 2020, an estimated $787K.
Parametrica Management first reported a position in Cantel Medical Corporation in Q4 2016 and held it in 4 quarters.
Parametrica Management's Cantel Medical Corporation position peaked at $787K in Q2 2020.
196 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2020.

Based on Parametrica Management's 13F filing for Q3 2020, filed 13 Nov 2020.